QNCX Competitors & Alternatives
Compare Quince Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
QNCX
Main Stock$29.55
Tradestie Score
50
Market Cap
$87.02M
Analyst Upside
+161.3%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
|
MGRX
Mangoceuticals, Inc. Common Stock
|
$0.40
|
$24.13M | - | 57 | Compare |
|
AIXI
XIAO-I Corporation American Depositary Shares
|
$2.69
|
$15.99M | - | 36 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.19
|
$3.50M | - | 53 | Compare |
|
VRAX
Virax Biolabs Group Limited Ordinary Shares
|
$2.67
|
$2.69M | - | 51 | Compare |
|
RENX
RENX
|
$1.78
|
- | - | 46 | Compare |
More QNCX Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry